BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 27003221)

  • 1. Treatment of Non-infectious Uveitic Macular Edema with the Intravitreal Dexamethasone Implant.
    Nobre-Cardoso J; Champion E; Darugar A; Fel A; Lehoang P; Bodaghi B
    Ocul Immunol Inflamm; 2017 Aug; 25(4):447-454. PubMed ID: 27003221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term evaluation of dexamethasone intravitreal implant in vitrectomized and non-vitrectomized eyes with macular edema secondary to non-infectious uveitis.
    Pelegrín L; de la Maza MS; Molins B; Ríos J; Adán A
    Eye (Lond); 2015 Jul; 29(7):943-50. PubMed ID: 25998942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and Efficacy of Intravitreal Dexamethasone Implant for Refractory Uveitic Macular Edema in Adults and Children.
    Ratra D; Barh A; Banerjee M; Ratra V; Biswas J
    Ocul Immunol Inflamm; 2018; 26(7):1034-1040. PubMed ID: 29394119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravitreal Dexamethasone Implant for the Treatment of Macular Edema in Chronic Non-infectious Uveitis.
    Tsang AC; Virgili G; Abtahi M; Gottlieb CC
    Ocul Immunol Inflamm; 2017 Oct; 25(5):685-692. PubMed ID: 27191685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EFFICACY AND SAFETY OF DEXAMETHASONE INTRAVITREAL IMPLANT FOR PERSISTENT UVEITIC CYSTOID MACULAR EDEMA.
    Khurana RN; Porco TC
    Retina; 2015 Aug; 35(8):1640-6. PubMed ID: 25741813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Effect of Age and Initial Central Retinal Thickness on Earlier Need of Repeat Ozurdex Treatment for Macular Edema Due to Retinal Vein Occlusion: A Retrospective Case Series.
    Lin CJ; Chen HS; Su CW; Tien PT; Lin JM; Chen WL; Kuo CY; Lai CT; Tsai YY
    J Ocul Pharmacol Ther; 2017 Dec; 33(10):763-772. PubMed ID: 28949790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic Steroid Sparing Effect of Intravitreal Dexamethasone Implant in Chronic Noninfectious Uveitic Macular Edema.
    Fabiani C; Vitale A; Emmi G; Lopalco G; Vannozzi L; Bacherini D; Guerriero S; Favale RA; Fusco F; Franceschini R; Frediani B; Iannone F; Galeazzi M; Tosi GM; Cantarini L
    J Ocul Pharmacol Ther; 2017 Sep; 33(7):549-555. PubMed ID: 28557602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dexamethasone Intravitreal Implant in the Treatment of Uveitic Macular Edema in the Perioperative Cataract Setting: A Case Series.
    Larochelle MB; Smith J; Dacey MS
    Am J Ophthalmol; 2016 Jun; 166():149-153. PubMed ID: 27066725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term outcome of an intravitreal dexamethasone implant for the treatment of noninfectious uveitic macular edema.
    Habot-Wilner Z; Sorkin N; Goldenberg D; Loewenstein A; Goldstein M
    Ophthalmologica; 2014; 232(2):77-82. PubMed ID: 25012541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two or more dexamethasone intravitreal implants in treatment-naïve patients with macular edema due to retinal vein occlusion: subgroup analysis of a retrospective chart review study.
    Dugel PU; Capone A; Singer MA; Dreyer RF; Dodwell DG; Roth DB; Shi R; Walt JG; Scott LC; Hollander DA;
    BMC Ophthalmol; 2015 Sep; 15():118. PubMed ID: 26337664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment with repeat dexamethasone implants results in long-term disease control in eyes with noninfectious uveitis.
    Tomkins-Netzer O; Taylor SR; Bar A; Lula A; Yaganti S; Talat L; Lightman S
    Ophthalmology; 2014 Aug; 121(8):1649-54. PubMed ID: 24650556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Dexamethasone Intravitreal Implant with Conventional Triamcinolone in Patients with Postoperative Cystoid Macular Edema.
    Mylonas G; Georgopoulos M; Malamos P; Georgalas I; Koutsandrea C; Brouzas D; Sacu S; Perisanidis C; Schmidt-Erfurth U;
    Curr Eye Res; 2017 Apr; 42(4):648-652. PubMed ID: 27612922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PROSPECTIVE EVALUATION OF A SUSTAINED-RELEASE DEXAMETHASONE INTRAVITREAL IMPLANT FOR CYSTOID MACULAR EDEMA IN QUIESCENT UVEITIS.
    Khurana RN; Bansal AS; Chang LK; Palmer JD; Wu C; Wieland MR
    Retina; 2017 Sep; 37(9):1692-1699. PubMed ID: 27893624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dexamethasone Inserts in Noninfectious Uveitis: A Single-Center Experience.
    Pohlmann D; Vom Brocke GA; Winterhalter S; Steurer T; Thees S; Pleyer U
    Ophthalmology; 2018 Jul; 125(7):1088-1099. PubMed ID: 29459041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dexamethasone Intravitreal Implant Injection in Eyes with Comorbid Hypotony.
    Kong X; Psaras C; Stewart JM
    Ophthalmol Retina; 2019 Nov; 3(11):993-997. PubMed ID: 31371197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dexamethasone intravitreal implant for treatment of uveitic persistent cystoid macular edema in vitrectomized patients.
    Adán A; Pelegrín L; Rey A; Llorenç V; Mesquida M; Molins B; Ríos J; Keller J
    Retina; 2013; 33(7):1435-40. PubMed ID: 23514796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dexamethasone intravitreal implant in patients with macular edema related to branch or central retinal vein occlusion twelve-month study results.
    Haller JA; Bandello F; Belfort R; Blumenkranz MS; Gillies M; Heier J; Loewenstein A; Yoon YH; Jiao J; Li XY; Whitcup SM; ; Li J
    Ophthalmology; 2011 Dec; 118(12):2453-60. PubMed ID: 21764136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion.
    Haller JA; Bandello F; Belfort R; Blumenkranz MS; Gillies M; Heier J; Loewenstein A; Yoon YH; Jacques ML; Jiao J; Li XY; Whitcup SM;
    Ophthalmology; 2010 Jun; 117(6):1134-1146.e3. PubMed ID: 20417567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of dexamethasone intravitreal implant for refractory macular edema in children.
    Lei S; Lam WC
    Can J Ophthalmol; 2015 Jun; 50(3):236-41. PubMed ID: 26040225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sustained-release dexamethasone intravitreal implant in juvenile idiopathic arthritis-related uveitis.
    Pichi F; Nucci P; Baynes K; Lowder CY; Srivastava SK
    Int Ophthalmol; 2017 Feb; 37(1):221-228. PubMed ID: 27221263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.